Suchergebnisse - "Hossein-khannazer, Nikoo"

PubPharm (14)

1

Evaluation of lymphocyte subtypes in COVID-19 patients

enthalten in: bioRxiv.org | 2023

von Rezaei, M. | Marjani, M. | Tabarsi, P. | +11

2

Evaluation of Lymphocyte Subtypes in COVID-19 Patients

enthalten in: Tanaffos | 2022

von Rezaei, M. | Marjani, M. | Tabarsi, P. | +11

3

Cross-talk between immune system and microbiota in COVID-19

enthalten in: Expert review of gastroenterology & hepatology | 2021

von Baradaran Ghavami, S. | Pourhamzeh, M. | Farmani, M. | +8

4

The nano-based theranostics for respiratory complications of COVID-19

enthalten in: Drug development and industrial pharmacy | 2021

von Ghasemzad, M. | Hashemian, S. | Memarnejadian, A. | +3

5

Application of Stem Cell-Derived Extracellular Vesicles as an Innovative Theranostics in Microbial Diseases

enthalten in: Frontiers in microbiology | 2021

von Keshavarz Alikhani, H. | Shokoohian, B. | Rezasoltani, S. | +4

6

An update to “novel therapeutic approaches for treatment of COVID-19”

enthalten in: Journal of molecular medicine | 2021

von Hossein-khannazer, N. | Shokoohian, B. | Shpichka, A. | +3

7

An update to “novel therapeutic approaches for treatment of COVID-19”

enthalten in: Journal of molecular medicine | 2021

von Hossein-khannazer, N. | Shokoohian, B. | Shpichka, A. | +3

8

An update to “novel therapeutic approaches for treatment of COVID-19”

enthalten in: Journal of molecular medicine | 2021

von Hossein-khannazer, N. | Shokoohian, B. | Shpichka, A. | +3

9

An update to "novel therapeutic approaches for treatment of COVID-19"

enthalten in: Journal of molecular medicine (Berlin, Germany) | 2021

von Hossein-Khannazer, N. | Shokoohian, B. | Shpichka, A. | +3

CommentOn: J Mol Med (Berl). 2020 Jun;98(6):789-803. - PMID 32494931

10

IBD Patients Could Be Silent Carriers for Novel Coronavirus and Less Prone to its Severe Adverse Events : True or False?

enthalten in: Cell journal | 2020

von Baradaran Ghavami, S. | Shahrokh, S. | Hossein-Khannazer, N. | +4